Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Happy Food Co. packs outside-the-box flavor into locally sourced meal kits
Finding the right mix of flavors for Kansas City’s pallette has been a trial-and-error effort for Happy Food Co., Jeff Glasco said. The Olathe-based direct-to-consumer meal kit company offers about 20 easy-to-prepare dinners infused with bold spices and outside-the-box local ingredients. Customer favorites include a bison cheeseburger quesadilla, butter-basted salmon, and soba noodle bowl with…
Ennovation Center helping food entrepreneurs avoid charring their dreams
In the seven years of leading a food business incubator, Lee Langerock has seen plenty of businesses — and dreams — sour. “We’ve had a front-row seat to the startup challenges and trials of food-based business,” said Langerock, the executive director of the Independence-based Ennovation Center. “The biggest pitfall we’ve witnessed is lack of practical,…
KCMO, Avis launch first-in-the-world test lab with 5,000 connected rental cars
Accelerating the Smart City initiative’s focus on enabling autonomous vehicles, the Kansas City area is now serving as the laboratory for a large test of thousands of connected rental cars. Avis Budget Group and the City of Kansas City, Missouri, announced Thursday the launch of the “Mobility Lab,” featuring a fleet of 5,000 internet-connected vehicles…
Document: Techstars raising a $400M startup fund
Accelerator and investment firm Techstars is working to raise a massive new fund to boost portfolio startups around the world. Techstars — which operates an accelerator program in Kansas City — is now raising a $400 million fund, according to a filing with the Securities and Exchange Commission. The fund more than doubles Techstars Ventures’…